| P50 | author | Serena Monti | Q39184587 |
| | Antonio Orlacchio | Q58284844 |
| | Fabrizio Chegai | Q58703871 |
| P2093 | author name string | Lorenzo Mannelli | |
| | Stefano Merolla | |
| P2860 | cites work | Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma | Q24235977 |
| | Inflammation and cancer | Q24649640 |
| | EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma | Q27860783 |
| | Inflammation and cancer: back to Virchow? | Q28036756 |
| | Basic and therapeutic aspects of angiogenesis | Q29615219 |
| | Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival | Q29616865 |
| | Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial | Q29617955 |
| | Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma | Q29617957 |
| | Transarterial chemoembolization using degradable starch microspheres and iodized oil in the treatment of advanced hepatocellular carcinoma: evaluation of tumor response, toxicity, and survival. | Q33375480 |
| | Transcatheter arterial chemoembolization using cisplatin powder mixed with degradable starch microspheres for colorectal liver metastases after FOLFOX failure: results of a phase I/II study | Q33404620 |
| | Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study | Q33631372 |
| | Hepatocellular carcinoma treated by conventional transarterial chemoembolization in field-practice: serum sodium predicts survival | Q33845513 |
| | DC bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization. | Q34499773 |
| | Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients | Q34569671 |
| | Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. | Q34581507 |
| | Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization. | Q34622672 |
| | Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma | Q35085486 |
| | Single-center phase II trial of transarterial chemoembolization with drug-eluting beads for patients with unresectable hepatocellular carcinoma: initial experience in the United States. | Q35322713 |
| | HCC and angiogenesis: possible targets and future directions | Q35698574 |
| | Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole livers | Q35979752 |
| | Transcatheter intraarterial therapies: rationale and overview | Q36104314 |
| | Comparison of survival rates after bland arterial embolization and ablation versus surgical resection for treating solitary hepatocellular carcinoma up to 7 cm. | Q36185946 |
| | Particle embolization of recurrent hepatocellular carcinoma after hepatectomy. | Q36441150 |
| | Hypoxia and hepatocellular carcinoma: The therapeutic target for hepatocellular carcinoma | Q36845140 |
| | Radiation-induced liver disease after stereotactic body radiotherapy for small hepatocellular carcinoma: clinical and dose-volumetric parameters | Q37277060 |
| | Transcatheter treatment of hepatocellular carcinoma with Doxorubicin-loaded DC Bead (DEBDOX): technical recommendations | Q37947148 |
| | Management of hepatocellular carcinoma with transarterial chemoembolization in the era of systemic targeted therapy | Q37964825 |
| | Role of the multidisciplinary team in the diagnosis and treatment of hepatocellular carcinoma | Q37989160 |
| | Safety and effectiveness of chemoembolization with drug-eluting beads for advanced-stage hepatocellular carcinoma | Q38113503 |
| | The Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Patients with Unresectable Hepatocellular Carcinoma Treated with Radioembolization. | Q38396459 |
| | In intermediate stage hepatocellular carcinoma: radioembolization with yttrium 90 or chemoembolization? | Q38984450 |
| | Doxorubicin-loaded QuadraSphere microspheres: plasma pharmacokinetics and intratumoral drug concentration in an animal model of liver cancer | Q39915670 |
| | Human liver cancer cells and endothelial cells incorporate iodised oil. | Q39989411 |
| | Pilot Study of Transcatheter Arterial Chemoembolization with Degradable Starch Microspheres in Patients With Hepatocellular Carcinoma | Q40560511 |
| | Chemo-occlusion for the treatment of liver cancer. A new technique using degradable starch microspheres | Q40662288 |
| | Embolotherapy: agents, clinical applications, and techniques | Q40692454 |
| | Extrahepatic blood supply to hepatocellular carcinoma: angiographic demonstration and transcatheter arterial chemoembolization | Q42487431 |
| | Arterial patency after repeated hepatic artery bland particle embolization. | Q43147861 |
| | Transarterial chemoembolization with epirubicin-eluting beads versus transarterial embolization before liver transplantation for hepatocellular carcinoma. | Q43185470 |
| | Transcatheter arterial embolization with only particles for the treatment of unresectable hepatocellular carcinoma. | Q43419259 |
| | Degradable starch microspheres versus ethiodol and doxorubicin in transarterial chemoembolization of hepatocellular carcinoma | Q44242159 |
| | Transarterial chemoembolization (TACE) for unresectable hepatocellular carcinoma in cirrhotics: functional hepatic reserve and survival. | Q44357857 |
| | Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents | Q44450176 |
| | Hepatic, arterial embolization in patients with malignant liver tumours (author's transl) | Q44471874 |
| | Transient blood flow reduction induced by intra-arterial injection of degradable starch microspheres. Experiments on rats | Q44596005 |
| | Dynamic evaluation and quantification of microvascularization during degradable starch microspheres transarterial Chemoembolisation (DSM-TACE) of HCC lesions using contrast enhanced ultrasound (CEUS): a feasibility study | Q44938978 |
| | Prognostic factors and prevention of radioembolization-induced liver disease | Q45850436 |
| | The prognostic value of vascular endothelial growth factor in hepatocellular carcinoma for predicting metastasis after curative resection. | Q45971991 |
| | Arterial embolization of unresectable hepatocellular carcinoma with use of microspheres, lipiodol, and cyanoacrylate. | Q46484885 |
| | Bland embolization of hepatocellular carcinoma using superabsorbent polymer microspheres | Q46548878 |
| | Transcatheter chemoembolization in the treatment of HCC in patients not eligible for curative treatments: midterm results of doxorubicin-loaded DC bead | Q46948670 |
| | Bland embolization in patients with unresectable hepatocellular carcinoma using precise, tightly size-calibrated, anti-inflammatory microparticles: first clinical experience and one-year follow-up. | Q47582292 |
| | Prognostic significance of the lymphocyte-to-neutrophil ratio in percutaneous fine-needle aspiration biopsy specimens of advanced nonsmall cell lung carcinoma | Q47756843 |
| | Mortality and hospital utilization for hepatocellular carcinoma in the United States | Q48604250 |
| | Safety and efficacy of 70-150 μm and 100-300 μm drug-eluting bead transarterial chemoembolization for hepatocellular carcinoma | Q50161892 |
| | Radioembolization With Yttrium-90 Resin Microspheres in Hepatocellular Carcinoma: A Multicenter Prospective Study. | Q50770174 |
| | A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead. | Q50956760 |
| | Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. | Q51021204 |
| | Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. | Q51082254 |
| | Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma. | Q51147086 |
| | New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer. | Q51218640 |
| | Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival. | Q51300479 |
| | Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival. | Q51642133 |
| | Chemoocclusion vs chemoperfusion for treatment of advanced hepatocellular carcinoma: a randomised trial. | Q53264581 |
| | Studies on the blood supply of tumors in man. III. Vascular patterns of the liver by hepatic arteriography in vivo. | Q55038120 |
| | Particle embolization for hepatocellular carcinoma. | Q55068027 |
| | Role of Kupffer cells in iodized oil embolization | Q57189860 |
| | Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: A phase 2 study | Q57763422 |
| | Escalated Focal Liver Radiation and Concurrent Hepatic Artery Fluorodeoxyuridine for Unresectable Intrahepatic Malignancies | Q61771738 |
| | Intraarterial adriamycin and lipiodol for inoperable hepatocellular carcinoma: a comparison with intravenous adriamycin | Q67682851 |
| | Hepatic artery embolization in 120 patients with unresectable hepatoma | Q70150850 |
| | Definition of hepatic tumor microcirculation by single photon emission computerized tomography (SPECT) | Q72390308 |
| | In vivo and in vitro analysis of the effectiveness of doxorubicin combined with temporary arterial occlusion in liver tumors | Q72706522 |
| | Transcatheter arterial embolization with or without cisplatin treatment of hepatocellular carcinoma. A randomized controlled study | Q72709851 |
| | Ethiodized oil emulsions in hepatic microcirculation: in vivo microscopy in animal models | Q73245943 |
| | Prospective and randomized trial of lipiodol-transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma: a comparison of epirubicin and doxorubicin (second cooperative study). The Cooperative Study Group for Liver Cancer Trea | Q73340876 |
| | The hepatic artery | Q74025631 |
| | RADIATION HEPATITIS | Q77134952 |
| | Accumulation of iodized oil within the nonneoplastic liver adjacent to hepatocellular carcinoma via the drainage routes of the tumor after transcatheter arterial embolization | Q77802566 |
| | A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma | Q83334221 |
| | Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria | Q84135417 |
| | Which transarterial therapy is best for hepatocellular carcinoma?--the evidence to date | Q84229719 |
| | A novel transcatheter arterial infusion chemotherapy using iodized oil and degradable starch microspheres for hepatocellular carcinoma: a prospective randomized trial | Q84801061 |
| | High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer | Q84989627 |
| | Transarterial chemoembolisation is not superior to embolisation alone: the recent European Association for the Study of the Liver (EASL) - European Organisation for Research and Treatment of Cancer (EORTC) guidelines | Q85645423 |
| | Survival, efficacy, and safety of small versus large doxorubicin drug-eluting beads TACE chemoembolization in patients with unresectable HCC | Q86036426 |
| | Chemoembolization of hepatocellular carcinoma | Q87117255 |
| | Temporary arterial embolization of liver parenchyma with degradable starch microspheres (EmboCept®S) in a swine model | Q87619334 |
| P433 | issue | 4 | |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| P304 | page(s) | 399-408 | |
| P577 | publication date | 2015-10-01 | |
| P1433 | published in | Hepatic oncology | Q27725477 |
| P1476 | title | Intermediate hepatocellular carcinoma: the role of transarterial therapy | |
| P478 | volume | 2 | |